Cibc Bancorp Usa Inc. Coherus Bio Sciences, Inc. Transaction History
Cibc Bancorp Usa Inc.
- $80.8 Billion
- Q3 2025
A detailed history of Cibc Bancorp Usa Inc. transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 11,429 shares of CHRS stock, worth $15,429. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,429Holding current value
$15,429% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CHRS
# of Institutions
124Shares Held
56.5MCall Options Held
149KPut Options Held
31K-
Black Rock Inc. New York, NY11.8MShares$15.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$13.9 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA5.1MShares$6.88 Million0.22% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$4.1 Million0.09% of portfolio
-
Geode Capital Management, LLC Boston, MA2.74MShares$3.7 Million0.0% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $105M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...